Search

everythinglearnresearchcommunity

for

Search:↓

Heavy metals might contribute to hair loss in Telogen Effluvium.

Poor nutrition is linked to increased hair loss in Canadian children.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Androgens may worsen a natural hair resting phase, possibly leading to hair loss.

Follicular Unit Transplantation is a reliable hair restoration method with a high success rate and minimal scarring.

The article explains how to tell apart and treat two common causes of hair loss in women.

CTE and FPHL are different hair loss types with unique causes.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Trichoscopy and histopathology can help identify post-COVID-19 hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Serum ferritin can help diagnose Telogen Effluvium.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

People with Telogen Effluvium have lower vitamin D levels.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Low ferritin levels might be linked to telogen effluvium, but vitamin D levels are not.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Etretinate treatment changed hair growth patterns in many patients.

COVID-19 may cause hair loss due to the virus's effects and stress from the pandemic.

COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.

COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.

"Alpenta" effectively reduces hair loss and improves hair growth in women with telogen effluvium.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Managing telogen effluvium is challenging due to limited scientific evidence.